Boots, the well-known High Street pharmacy and retail chain, has been sold to Canada’s billionaire Weston family in a deal worth £6.7 billion ($8.9 billion). Wittington Investments, the Weston family’s holding company, confirmed on Wednesday it had agreed to acquire the 177-year-old retailer from US private equity firm Sycamore Partners and the Pessina family.

The Acquisition Details

The sale encompasses Boots’ extensive retail operations across the UK and Ireland, Boots Opticians, the No7 Beauty Company, and its businesses in Thailand, including franchised operations. The Canadian Weston family, known for their ownership of the Loblaws grocery chain and Shoppers Drug Mart pharmacy outlets in Canada, will control the acquired assets. Wittington Investments has secured this ownership in partnership with Fairfax Financial Holdings, a Toronto-based holding company. The transaction is subject to regulatory approval and is expected to be finalised in the first quarter of 2027, as reported by The Guardian.

Notably, the deal does not include Boots Group’s Farmacias Benavides in Mexico or Alliance Healthcare Deutschland in Germany, which will be retained by Sycamore Partners and Stefano Pessina and his family.

Future Outlook and Expert Insights

Galen Weston, who chairs Wittington and is set to become chairman of Boots, stated that the new owners see a “meaningful opportunity to make a great business even better through stable long-term ownership, further capital investment, and the renewed operating focus”. He indicated plans for shop upgrades and an expansion of healthcare services.

Retail expert Catherine Shuttleworth, CEO of Savvy Marketing, suggested that while shoppers are unlikely to see immediate changes, they can “expect over time an improved shopping experience as the new owners invest in the business.” She highlighted health and beauty as a “massive area for growth” that will benefit from fresh investment. Veteran retail analyst Richard Hyman described the Weston family as “the most encouraging ownership of Boots for many, many years”, noting their historical tendency to take a longer-term view. He believes Boots has an opportunity to leverage its Advantage Card loyalty scheme and expand services across its store network.

Boots’ Enduring High Street Presence

Boots began as a humble herbalist store in Nottingham in 1849, founded by John Boot, offering affordable alternatives to traditional medicines. It has since grown into a British High Street staple, expanding its product range beyond health to include beauty products, meal deals, and travel accessories. Despite challenges like reduced footfall due to remote working and hundreds of store closures in recent years, Boots still operates approximately 1,800 stores across the UK, employing 51,000 people. Its most recent annual results reported sales of £7.5 billion, a 3.2% increase on 2024 figures. The company also provides vital healthcare support, including vaccines, eye, and hearing tests, and its popular Advantage Card loyalty scheme launched in 1997.

The Weston Family’s Retail Empire

The acquisition marks a return for the Canadian branch of the Weston family to the UK high street, having previously owned the London department store Selfridges from 2003 until its sale for £4 billion in 2022. Their extensive retail portfolio also includes the Canadian grocery chain Loblaws and the pharmacy business Shoppers Drug Mart. A separate UK branch of the Weston family holds a majority stake in Associated British Foods, the parent company of Primark. As reported by the BBC, the Westons were ranked fifth on this year’s Sunday Times Rich List, with a combined fortune estimated at almost £19 billion.

A History of Ownership Transitions

The sale follows a period of frequent ownership changes and attempted sales for Boots. Sycamore Partners had owned the retailer for only 18 months, a period retail expert Catherine Shuttleworth described as an “unhelpful distraction”. Over the past two decades, Boots has seen several ownership discussions and changes. Stefano Pessina, who initially took Boots private with KKR in 2007, has maintained a stake through various private equity ownerships and its merger and demerger from Walgreens. In 2022, Walgreens had put Boots up for sale with a suggested price of up to £10 billion, but plans were dropped as potential buyers struggled to raise funds. A subsequent plan to float the business at a valuation of around £7 billion was also abandoned in 2024.

For Liverpool and Merseyside residents, and indeed the broader UK audience, the change in ownership could signal a period of renewed investment in a familiar high street brand. The new owners’ stated intent to upgrade shops and expand healthcare services suggests a focus on enhancing the in-store experience and the range of essential services provided by Boots.